head and neck neoplasms (5)
lymphoma, large b-cell, diffuse (5)
receptors, chimeric antigen (5)
antineoplastic combined chemotherapy protocols (4)
algorithms (2)
antibodies, monoclonal, humanized (2)
b7-h1 antigen (2)
biological products (2)
breast neoplasms (2)
gene regulatory networks (2)
immune checkpoint inhibitors (2)
immunotherapy, adoptive (2)
neoplasm recurrence, local (2)
precursor cell lymphoblastic leukemia-lymphoma (2)
protein kinase inhibitors (2)
thrombocytopenia (2)
t-lymphocytes (2)
adenine (1)
albumins (1)
anemia (1)
anemia, sickle cell (1)
angiogenesis inhibitors (1)
bevacizumab (1)
biomarkers (1)
biomarkers, tumor (1)
b-lymphocytes (1)
bone marrow (1)
bone neoplasms (1)
bone resorption (1)
breast neoplasms, male (1)
carcinoma (1)
carcinoma, non-small-cell lung (1)
collagen type i (1)
cost of illness (1)
cpg islands (1)
cyclophosphamide (1)
depressive disorder, major (1)
doxorubicin (1)
erlotinib hydrochloride (1)
genomics (1)
hematologic neoplasms (1)
hematopoietic stem cell transplantation (1)
lung neoplasms (1)
lymphoma, b-cell (1)
lymphoma, follicular (1)
multiple myeloma (1)
mutation (1)
neoplasm proteins (1)
neoplastic cells, circulating (1)
neurotoxicity syndromes (1)